BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(11): 1301-1314 [PMID: 19294759 DOI: 10.3748/wjg.15.1301]
URL: https://www.wjgnet.com/1007-9327/full/v15/i11/1301.htm
Number Citing Articles
1
Manar M. Ismail, Heba K. Morsi, Nahla A. B. Abdulateef, Maissa K. Noaman, Ghada A. Abou El-Ella. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillanceScandinavian Journal of Clinical and Laboratory Investigation 2017; 77(3): 175 doi: 10.1080/00365513.2017.1286684
2
Giuseppe Derosa, Pamela Maffioli. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 3 doi: 10.1007/978-94-007-7675-3_13
3
John FP Bridges, Gisselle Gallego, Barri M Blauvelt. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needsHealth Research Policy and Systems 2011; 9(1) doi: 10.1186/1478-4505-9-32
4
Chen-Shiou Wu, Teng-Yu Lee, Ruey-Hwang Chou, Chia-Jui Yen, Wei-Chien Huang, Chung-Yi Wu, Yung-Luen Yu, Isabelle A. Chemin. Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus–Related Hepatocellular CarcinomaPLoS ONE 2014; 9(6): e99959 doi: 10.1371/journal.pone.0099959
5
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang, Li Yang. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular CarcinomaMedicine 2016; 95(17): e3448 doi: 10.1097/MD.0000000000003448
6
Matthew R. Woeste, Anne E. Geller, Robert C. G. Martin, Hiram C. Polk. Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular CancerAnnals of Surgical Oncology 2021; 28(3): 1499 doi: 10.1245/s10434-020-09414-5
7
Mohamed IF Shariff, I Jane Cox, Asmaa I Gomaa, Shahid A Khan, Wladyslaw Gedroyc, Simon D Taylor-Robinson. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeuticsExpert Review of Gastroenterology & Hepatology 2009; 3(4): 353 doi: 10.1586/egh.09.35
8
Magdy Hamed Attwa, Shahira Aly El-Etreby. Guide for diagnosis and treatment of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(12): 1632-1651 doi: 10.4254/wjh.v7.i12.1632
9
Zu-Yau Lin, Chun-Chieh Wu, Yen-Hwang Chuang, Wan-Long Chuang. Clinical utility of a simple primary culture method in hepatocellular carcinoma patientsJournal of Gastroenterology and Hepatology 2015; 30(2): 352 doi: 10.1111/jgh.12693
10
Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Sara Lonardi, Jiri Tomasek, Jean‐Marc Phelip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Kun Liang, Kenyon D. Ogburn, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu, Pierre Nahon. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiologyLiver International 2021;  doi: 10.1111/liv.14994
11
JIANPING WANG, DEJIE LIU, XIAOHONG LIANG, LIFEN GAO, XUETIAN YUE, YANG YANG, CHUNHONG MA, JUN LIU. Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinomaMolecular Medicine Reports 2013; 8(5): 1531 doi: 10.3892/mmr.2013.1700
12
Constantinos T. Sofocleous, Panagiotis Sideras, Elena N. Petre. “How We Do it”—A Practical Approach to Hepatic Metastases Ablation TechniquesTechniques in Vascular and Interventional Radiology 2013; 16(4): 219 doi: 10.1053/j.tvir.2013.08.005
13
Kevin Z Qu, Ke Zhang, Wanlong Ma, Hairong Li, Xiuqiang Wang, Xi Zhang, Francis Giles, Michelle Lai, Nezam H Afdhal, Maher Albitar. Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver diseaseJournal of Gastroenterology and Hepatology 2011; 26(4): 751 doi: 10.1111/j.1440-1746.2010.06491.x
14
Yeong Hee Ahn, Park Min Shin, Eun Sun Ji, Hoguen Kim, Jong Shin Yoo. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometryAnalytical and Bioanalytical Chemistry 2012; 402(6): 2101 doi: 10.1007/s00216-011-5646-3
15
Ewelina Jurewicz, Irena Kasacka, Edward Bańkowski, Anna Filipek. Identification and localization of S100A6 in human umbilical cordCell Biology International 2012; 36(1): 109 doi: 10.1042/CBI20110233
16
Russell N. Wesson, Andrew M. Cameron. Primary Liver Cancer2012; : 79 doi: 10.1007/978-1-61779-863-4_5
17
Saber Ismail, Wael Mayah, Hassan El Battia, Hanaa Gaballah, Asif Jiman-Fatani, Hala Hamouda, Mohamed A. Afifi, Nehal Elmashad, Sherif El Saadany. Plasma Nuclear Factor Kappa B and Serum Peroxiredoxin 3 in Early Diagnosis of Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2015; 16(4): 1657 doi: 10.7314/APJCP.2015.16.4.1657
18
Elaine Holmes, Ian D. Wilson, John C. Lindon. The Handbook of Metabolic Phenotyping2019; : 1 doi: 10.1016/B978-0-12-812293-8.00001-3
19
Reetta Holmila, Athena Sklias, David C. Muller, Davide Degli Esposti, Paule Guilloreau, James Mckay, Suleeporn Sangrajrang, Petcharin Srivatanakul, Pierre Hainaut, Philippe Merle, Zdenko Herceg, Andre Nogueira da Costa, John Luk. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaPLOS ONE 2017; 12(3): e0174265 doi: 10.1371/journal.pone.0174265
20
Longbo Hu, Wenxia Yao, Fang Wang, Xia Rong, Tao Peng, Hong Wanjin. GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV SecretionPLoS ONE 2014; 9(3): e90553 doi: 10.1371/journal.pone.0090553
21
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?Acta Tropica 2013; 128(3): 542 doi: 10.1016/j.actatropica.2013.07.024
22
Sivapatham Sundaresan, Palanirasu Rajapriya. Translational Research in Cancer2021;  doi: 10.5772/intechopen.94769
23
Dina M. Rasheed Bahgat, Rasha Mohamad Hosny Shahin, Nada Nasr Makar, Ashraf Omar Abdel Aziz, Shereen Shoukry Hunter. Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control StudyJournal of Clinical Laboratory Analysis 2016; 30(1): 36 doi: 10.1002/jcla.21806
24
Sudhakar Rajoria, Sarita Rani, Dasharath Chaudhari, Sanyog Jain, Umesh Gupta. Glycine-Poly-L-Lactic Acid Copolymeric Nanoparticles for the Efficient Delivery of BortezomibPharmaceutical Research 2019; 36(11) doi: 10.1007/s11095-019-2686-4
25
Huaqing Cui, Feng Wu, Yanling Sun, Guocai Fan, Qingming Wang. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinomaBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-356
26
Catharine M Sturgeon, Michael J Duffy, Barry R Hofmann, Rolf Lamerz, Herbert A Fritsche, Katja Gaarenstroom, Johannes Bonfrer, Thorsten H Ecke, H Barton Grossman, Peter Hayes, Ralf-Thorsten Hoffmann, Seth P Lerner, Florian Löhe, Johanna Louhimo, Ihor Sawczuk, Kazuhisa Taketa, Eleftherios P Diamandis. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersClinical Chemistry 2010; 56(6): e1 doi: 10.1373/clinchem.2009.133124
27
Heba S. El Deen, Hemmat E. El Haddad. Significance of hepatocyte growth factor concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinomaThe Egyptian Journal of Internal Medicine 2015; 27(3): 92 doi: 10.4103/1110-7782.165437
28
M.-O. Riener. Diagnose von Tumoren der Leber und GallenwegeDer Pathologe 2011; 32(S2): 304 doi: 10.1007/s00292-011-1467-6
29
Andrew X Zhu, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon, Davide Pastorelli, Jean-Frederic Blanc, Hyun Cheol Chung, Ari D Baron, Tulio Eduardo Flesch Pfiffer, Takuji Okusaka, Katerina Kubackova, Jorg Trojan, Javier Sastre, Ian Chau, Shao-Chun Chang, Paolo B Abada, Ling Yang, Jonathan D Schwartz, Masatoshi Kudo. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialThe Lancet Oncology 2015; 16(7): 859 doi: 10.1016/S1470-2045(15)00050-9
30
Brian C. Grieb, Laura W. Goff, Lipika Goyal, Crystal S. Denlinger. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future FrontiersAmerican Society of Clinical Oncology Educational Book 2019; (39): 248 doi: 10.1200/EDBK_237555
31
Jin Un Kim, Mohamed I F Shariff, Mary M E Crossey, Maria Gomez-Romero, Elaine Holmes, I Jane Cox, Haddy K S Fye, Ramou Njie, Simon D Taylor-Robinson. Hepatocellular carcinoma: Review of disease and tumor biomarkersWorld Journal of Hepatology 2016; 8(10): 471-484 doi: 10.4254/wjh.v8.i10.471
32
María Muros-Ortega, Mª Sacramento Díaz-Carrasco, Antonio Capel, Miguel Ángel Calleja, Fernando Martínez. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinomaInternational Journal of Clinical Pharmacy 2013; 35(6): 1105 doi: 10.1007/s11096-013-9831-7
33
Yeong Hee Ahn, Eun Sun Ji, Park Min Shin, Kwang Hoe Kim, Yong-Sam Kim, Jeong Heon Ko, Jong Shin Yoo. A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometryThe Analyst 2012; 137(3): 691 doi: 10.1039/C1AN15775B
34
Kohei Ogawa, Toshimi Kaido, Hideaki Okajima, Yasuhiro Fujimoto, Atsushi Yoshizawa, Shintaro Yagi, Tomohide Hori, Taku Iida, Yasutsugu Takada, Shinji Uemoto. Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2019; 26(2): 73 doi: 10.1002/jhbp.602
35
Hao Yang, Guo-Dong Chen, Feng Fang, Zhen Liu, Stephanie Hiu Yan Lau, Jin-Fan Zhang, Wan Yee Lau, Lian-Yue Yang. Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular CarcinomaThe International Journal of Biological Markers 2013; 28(3): 286 doi: 10.5301/JBM.5000015
36
Mika Fujiwara, Shirley Kwok, Hirohisa Yano, Reetesh K. Pai. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsiesCancer Cytopathology 2012; 120(4): 230 doi: 10.1002/cncy.21190
37
János Fehér, Gabriella Lengyel. Hepatocellular carcinoma: occurrence, risk factors, biomarkersOrvosi Hetilap 2010; 151(23): 933 doi: 10.1556/oh.2010.28900
38
Hosni M. Salama, Hanan Abdel-Haleem, Fatma M. Taha, Rasha A. Abdel-Azeez, Raghda N. Marzaban, Saeed M. El-Nahaas, Tarneem Darwish. Plasma proteosome level as a potential marker for hepatocellular carcinomaArab Journal of Gastroenterology 2013; 14(3): 87 doi: 10.1016/j.ajg.2013.09.002
39
Young Mi Hong, K. T. Yoon, Mong Cho. Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinomaBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08124-9
40
Zhongguo Zhou, Minshan Chen. Radiofrequency Ablation for Small Hepatocellular Carcinoma2016; : 39 doi: 10.1007/978-94-017-7258-7_5
41
Toshimi Kaido, Kohei Ogawa, Akira Mori, Yasuhiro Fujimoto, Takashi Ito, Koji Tomiyama, Yasutsugu Takada, Shinji Uemoto. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinomaSurgery 2013; 154(5): 1053 doi: 10.1016/j.surg.2013.04.056
42
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of ManagementISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
43
Yeong Hee Ahn, Jin Young Kim, Jong Shin Yoo. Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methodsMass Spectrometry Reviews 2015; 34(2): 148 doi: 10.1002/mas.21428
44
K. Hamdy, R. Al Swaff, H. A. Hussein, M. Gamal. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinomaJournal of Endocrinological Investigation 2015; 38(11): 1225 doi: 10.1007/s40618-015-0379-3
45
Ming-Tzung Lin, Chao-Long Chen, Chih-Chi Wang, Yu-Fan Cheng, Hock-Liew Eng, Jing-Houng Wang, King-Wah Chiu, Chuan-Mo Lee, Tsung-Hui Hu. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patientsJournal of Gastroenterology and Hepatology 2011; 26(4): 745 doi: 10.1111/j.1440-1746.2010.06501.x
46
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseasesComparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
47
Ping Wu, Jean Jacques Dugoua, Oghenowede Eyawo, Edward J Mills. Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysisJournal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-112
48
Nikolaus Kohles, Stefan Holdenrieder. Biomarkers in Cancer2014; : 1 doi: 10.1007/978-94-007-7744-6_38-1
49
Jorge A. Marrero, Masatoshi Kudo, Jean‐Pierre Bronowicki. The Challenge of Prognosis and Staging for Hepatocellular CarcinomaThe Oncologist 2010; 15(S4): 23 doi: 10.1634/theoncologist.2010-S4-23
50
Se Hun Kang, Do Young Kim, Soung Min Jeon, Sang Hoon Ahn, Jun Yong Park, Seung Up Kim, Ja Kyung Kim, Kwan Sik Lee, Chae Yoon Chon, Kwang-Hyub Han. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levelsEuropean Journal of Gastroenterology & Hepatology 2012; 24(7): 849 doi: 10.1097/MEG.0b013e3283535c34
51
Gehan H. Ibrahim, Moushira A. Mahmoud, Nagwa M. Aly. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patientsMolecular Biology Reports 2013; 40(12): 7069 doi: 10.1007/s11033-013-2829-3
52
Yeonjung Ha, Ju Hyun Shim, Seon-Ok Kim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee. Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysisJournal of Gastroenterology and Hepatology 2014; 29(4): 787 doi: 10.1111/jgh.12452
53
Minoru Matsubara, Hidenori Shiraha, Jyunro Kataoka, Masaya Iwamuro, Shigeru Horiguchi, Shin-ichi Nishina, Nobuyuki Takaoka, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Kazuhide Yamamoto. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2012; 27(10): 1602 doi: 10.1111/j.1440-1746.2012.07173.x
54
Anan H. Said, Kirti Shetty, Ying Li, Boris Blechacz, Ernest Hawk, Lopa Mishra. Handbook of Gastrointestinal Cancer2012; : 161 doi: 10.1002/9781118423318.ch7
55
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
56
Takeshi Ishihara, Isao Fukuda, Atsushi Morita, Yoshihiko Takinami, Hiroyuki Okamoto, Shin-Ichiro Nishimura, Yoshito Numata. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinomaJournal of Proteomics 2011; 74(10): 2159 doi: 10.1016/j.jprot.2011.06.010
57
Li Huo, Zhanhong Wu, Hongming Zhuang, Zhe Fu, Yonghong Dang. Dual Time Point C-11 Acetate PET Imaging Can Potentially Distinguish Focal Nodular Hyperplasia From Primary Hepatocellular CarcinomaClinical Nuclear Medicine 2009; 34(12): 874 doi: 10.1097/RLU.0b013e3181bed06e
58
Tomokazu Kawaoka, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo, Kazuaki Chayama. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenibHepatology Research 2014; 44(13): 1320 doi: 10.1111/hepr.12307
59
Ming Shi, Min-Shan Chen, Karthik Sekar, Chee-Kiat Tan, London Lucien Ooi, Kam M. Hui. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinomaEuropean Journal of Cancer 2014; 50(5): 928 doi: 10.1016/j.ejca.2013.11.026
60
Ian Chau, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon, Davide Pastorelli, Jean-Frédéric Blanc, Masatoshi Kudo, Tulio Pfiffer, Etsuro Hatano, Hyun Cheol Chung, Katerina Kopeckova, Jean-Marc Phelip, Giovanni Brandi, Shinichi Ohkawa, Chung-Pin Li, Takuji Okusaka, Yanzhi Hsu, Paolo B. Abada, Andrew X. Zhu. Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH studyBritish Journal of Cancer 2018; 119(1): 19 doi: 10.1038/s41416-018-0103-0
61
Siwei Wei, Yuliana Suryani, G. A. Nagana Gowda, Nicholas Skill, Mary Maluccio, Daniel Raftery. Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite ProfilingMetabolites 2012; 2(4): 701 doi: 10.3390/metabo2040701
62
Fatma Shehata, Nihad Abdel Monem, Mohamed Sakr, Samar Kasem, Mahmoud Balbaa. Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinomaMedical Oncology 2013; 30(3) doi: 10.1007/s12032-013-0673-x
63
Hammad Zafar, Mamoon Ur Rashid, Deepika Sarvepalli, Muzammil Muhammad Khan, Bayarmaa Mandzhieva, Akriti Gupta Jain, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers2020; : 287 doi: 10.1007/978-3-030-48405-7_13
64
David J. S. Becker-Weidman, Bobby Kalb, Puneet Sharma, Hiroumi D. Kitajima, Christina R. Lurie, Zhengjia Chen, James R. Spivey, Stuart J. Knechtle, Steven I. Hanish, N. Volkan Adsay, Alton B. Farris, Diego R. Martin. Hepatocellular Carcinoma Lesion Characterization: Single-Institution Clinical Performance Review of Multiphase Gadolinium-enhanced MR Imaging—Comparison to Prior Same-Center Results after MR Systems ImprovementsRadiology 2011; 261(3): 824 doi: 10.1148/radiol.11110157
65
Yeong Hee Ahn, Eun Sun Ji, Na Ree Oh, Yong-Sam Kim, Jeong Heon Ko, Jong Shin Yoo. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometryJournal of Proteomics 2014; 106: 221 doi: 10.1016/j.jprot.2014.04.031
66
Yeong Hee Ahn, Park Min Shin, Na Ree Oh, Gun Wook Park, Hoguen Kim, Jong Shin Yoo. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasmaJournal of Proteomics 2012; 75(17): 5507 doi: 10.1016/j.jprot.2012.06.027
67
Keun Na, Seul-Ki Jeong, Min Jung Lee, Sang Yun Cho, Sun A Kim, Min-Ji Lee, Si Young Song, Hoguen Kim, Kyung Sik Kim, Hyun Woong Lee, Young-Ki Paik. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patientsInternational Journal of Cancer 2013; 133(2): 408 doi: 10.1002/ijc.28020
68
Keun Na, Minjoo Kim, Chae-Yeon Kim, Jong-Sun Lim, Jin-Young Cho, Heon Shin, Hyo Jin Lee, Byeong Jun Kang, Dai Hoon Han, Hoguen Kim, Ja-Hyun Baik, Magdalena Swiatek-de Lange, Johann Karl, Young-Ki Paik. Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell GrowthJournal of Proteome Research 2020; 19(12): 4867 doi: 10.1021/acs.jproteome.0c00787
69
Kun-Ming Rau, Chien-Ting Liu, Yu-Chiao Hsiao, Kai-Yin Hsiao, Tzu-Min Wang, Wei-Shan Hung, Yu-Li Su, Wei-Ching Liu, Cheng-Hsu Wang, Hsueh-Ling Hsu, Po-Heng Chuang, Ju-Chien Cheng, Ching-Ping Tseng. Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment ResponseJournal of Clinical Medicine 2020; 9(1): 188 doi: 10.3390/jcm9010188
70
Caroline D. M. Witjes, Susanna M. van Aalten, Ewout W. Steyerberg, Gerard J. J. M. Borsboom, Robert A. de Man, Cornelis Verhoef, Jan N. M. IJzermans. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysisHepatology International 2013; 7(1): 59 doi: 10.1007/s12072-012-9374-3
71
C.-C. Liu, H. Yang, R. Zhang, J.-J. Zhao, D.-J. Hao. Tumour-associated antigens and their anti-cancer applicationsEuropean Journal of Cancer Care 2017; 26(5): e12446 doi: 10.1111/ecc.12446
72
Andre Nogueira da Costa, Amelie Plymoth, Daniela Santos-Silva, Sandra Ortiz-Cuaran, Suzy Camey, Paule Guilloreau, Suleeporn Sangrajrang, Thiravud Khuhaprema, Maimuna Mendy, Olufunmilayo A. Lesi, Hee-Kyung Chang, Jin-Kyoung Oh, Duk-Hee Lee, Hai-Rim Shin, Gregory D. Kirk, Philippe Merle, Laura Beretta, Pierre Hainaut. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinomaInternational Journal of Cancer 2015; 136(1): 172 doi: 10.1002/ijc.28953
73
JING ZHU, FENG JIANG, HONG-BING NI, MING-BING XIAO, BU-YOU CHEN, WEN-KAI NI, CUI-HUA LU, RUN-ZHOU NI. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinomaExperimental and Therapeutic Medicine 2013; 5(1): 89 doi: 10.3892/etm.2012.783
74
Qian Shang, Jun-Feng Xiang, Ya-Lin Tang. NMR-based metabonomics: a useful platform of oncology researchBioanalytical Reviews 2010; 1(2-4): 117 doi: 10.1007/s12566-010-0009-7
75
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson, Jeremy K. Nicholson. The promise of metabolic phenotyping in gastroenterology and hepatologyNature Reviews Gastroenterology & Hepatology 2015; 12(8): 458 doi: 10.1038/nrgastro.2015.114
76
Nikolaus Kohles, Stefan Holdenrieder. Biomarkers in CancerBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 303 doi: 10.1007/978-94-007-7681-4_38
77
Ana L. M. Pavan, Marwa Benabdallah, Marie-Ange Lebre, Diana Rodrigues de Pina, Faouzi Jaziri, Antoine Vacavant, Achraf Mtibaa, Hawa Mohamed Ali, Manuel Grand-Brochier, Hugo Rositi, Benoît Magnin, Armand Abergel, Pascal Chabrot. A parallel framework for HCC detection in DCE-MRI sequences with wavelet-based description and SVM classificationProceedings of the 33rd Annual ACM Symposium on Applied Computing 2018; : 14 doi: 10.1145/3167132.3167167
78
Toshimi Kaido, Satoshi Morita, Sachiko Tanaka, Kohei Ogawa, Akira Mori, Etsuro Hatano, Shinji Uemoto. Long-Term Outcomes of Hepatic Resection versus Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score-Matching StudyDisease Markers 2015; 2015: 1 doi: 10.1155/2015/425926
79
Anita Gupta. Emerging applications of lectins in cancer detection and biomedicineMaterials Today: Proceedings 2020; 31: 651 doi: 10.1016/j.matpr.2020.05.810
80
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
81
Fatih Özdemir, Adil Baskiran. The Importance of AFP in Liver Transplantation for HCCJournal of Gastrointestinal Cancer 2020; 51(4): 1127 doi: 10.1007/s12029-020-00486-w
82
Kwang Hoe Kim, Jin Young Kim, Jong Shin Yoo. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinomaExpert Review of Proteomics 2019; 16(7): 553 doi: 10.1080/14789450.2019.1626235
83
Ana F. Brito, Mónica Mendes, Ana M. Abrantes, José G. Tralhão, Maria F. Botelho. Positron Emission Tomography Diagnostic Imaging in Multidrug-Resistant Hepatocellular Carcinoma: Focus on 2-Deoxy-2-(18F)Fluoro-d-GlucoseMolecular Diagnosis & Therapy 2014; 18(5): 495 doi: 10.1007/s40291-014-0106-3
84
Amandeep Kaur, Ajay Pal Singh Chauhan, Ashwani Kumar Aggarwal. An automated slice sorting technique for multi-slice computed tomography liver cancer images using convolutional networkExpert Systems with Applications 2021; 186: 115686 doi: 10.1016/j.eswa.2021.115686
85
Madhvi Patel, Mohamed I.F. Shariff, Nimzing G. Ladep, Andrew V. Thillainayagam, Howard C. Thomas, Shahid A. Khan, Simon D. Taylor-Robinson. Hepatocellular carcinoma: diagnostics and screeningJournal of Evaluation in Clinical Practice 2012; 18(2): 335 doi: 10.1111/j.1365-2753.2010.01599.x
86
Bo Li, Boan Li, Tongsheng Guo, Zhiqiang Sun, Xiaohan Li, Xiaoxi Li, Han Wang, Weijiao Chen, Peng Chen, Yuanli Mao. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular CarcinomaBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5358615
87
Ilse du Preez, Nomathamsanqa P. Sithebe. The use of metabolomics as a tool to investigate hepatitis CMetabolomics 2013; 9(2): 497 doi: 10.1007/s11306-012-0467-8
88
Kyeong-Ah Lee, Ji-Young Ahn, Sang-Hee Lee, Simranjeet Singh Sekhon, Dae-Ghon Kim, Jiho Min, Yang-Hoon Kim. Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC)Scientific Reports 2015; 5(1) doi: 10.1038/srep10897
89
Amy C. McClune, Myron J. Tong. Chronic Hepatitis B and Hepatocellular CarcinomaClinics in Liver Disease 2010; 14(3): 461 doi: 10.1016/j.cld.2010.05.009
90
Anna Fabijańska, Antoine Vacavant, Marie-Ange Lebre, Ana L. M. Pavan, Diana R. de Pina, Armand Abergel, Pascal Chabrot, Benoît Magnin. Computer Vision and GraphicsLecture Notes in Computer Science 2018; 11114: 319 doi: 10.1007/978-3-030-00692-1_28
91
Walifa Waqar, Sidra Asghar, Sobia Manzoor, Gianfranco D. Alpini. Platelets’ RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodulesPLOS ONE 2021; 16(9): e0256739 doi: 10.1371/journal.pone.0256739
92
Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Yee Lau, Tian Yang. Clinical utility of serum biomarkers for hepatocellular carcinomaBiomarkers in Medicine 2021; 15(3): 151 doi: 10.2217/bmm-2020-0474
93
Aymeric Becq, Christian Mateescu, David Khayat, Mohamed Bouattour. Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid AdenocarcinomaMedicine 2015; 94(27): e1101 doi: 10.1097/MD.0000000000001101
94
Sayo Kobayashi, Kazuhiro Nouso, Hideaki Kinugasa, Yasuto Takeuchi, Takeshi Tomoda, Koji Miyahara, Hiroaki Hagihara, Kenji Kuwaki, Hideki Onishi, Shinichiro Nakamura, Fusao Ikeda, Yasuhiro Miyake, Hidenori Shiraha, Akinobu Takaki, Kazuhide Yamamoto. Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinomaHepatology Research 2012; 42(12): 1187 doi: 10.1111/j.1872-034X.2012.01044.x
95
Hoda Aly Abd El Moety, Dalia Aly Maharem, Salwa Hamdy Gomaa. Serotonin: is it a marker for the diagnosis of hepatocellular carcinoma in cirrhotic patients?Alexandria Journal of Medicine 2013; 49(4): 369 doi: 10.1016/j.ajme.2013.03.010
96
Eun Sun Ji, Heeyoun Hwang, Gun Wook Park, Ju Yeon Lee, Hyun Kyoung Lee, Na Young Choi, Hoi Keun Jeong, Kwang Hoe Kim, Jin Young Kim, Seungho Lee, Yeong Hee Ahn, Jong Shin Yoo. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometryAnalytical and Bioanalytical Chemistry 2016; 408(27): 7761 doi: 10.1007/s00216-016-9878-0
97
Felix H. Shek, Tracy C. W. Lai, Sarwat Fatima, Nikki P. Lee. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine2013; : 57 doi: 10.1007/978-1-62703-456-2_4
98
Hua Yang, Fuxia Xiong, Ruizhao Qi, Zhenwen Liu, Ming Lin, Jingan Rui, Jing Su, Rouli Zhou. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinomaJournal of Surgical Oncology 2010; 101(5): 363 doi: 10.1002/jso.21489
99
Sen-Yung Hsieh, Jung-Ru He, Ming-Chin Yu, Wei-Chen Lee, Tse-Chin Chen, Shao-Jung Lo, Rabindranath Bera, Chang-Mung Sung, Cheng-Tang Chiu. Secreted ERBB3 Isoforms Are Serum Markers for Early Hepatoma in Patients with Chronic Hepatitis and CirrhosisJournal of Proteome Research 2011; 10(10): 4715 doi: 10.1021/pr200519q
100
Li‑Min Luo, Hu Xia, Rong Shi, Jun Zeng, Xin‑Rui Liu, Min Wei. The association between aquaporin‑1 expression, microvessel density and the clinicopathological features of hepatocellular carcinomaOncology Letters 2017;  doi: 10.3892/ol.2017.7106
101
Miriama Smajerova, Hana Petrasova, Jirina Little, Petra Ovesna, Tomas Andrasina, Vlastimil Valek, Eva Nemcova, Barbora Miklosova. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysisWorld Journal of Gastroenterology 2016; 22(38): 8605-8614 doi: 10.3748/wjg.v22.i38.8605
102
Gaeun Lee, Jieun Kim, June-Goo Lee, Geunhwi Ahn, Seong Ho Park, So Yeon Kim, Kyung Won Kim, Seung Soo Lee, Namkug Kim, Hiroshi Fujita, Feng Lin, Jong Hyo Kim. Automatic hepatocellular carcinoma lesion detection with dynamic enhancement characteristic from multi-phase CT imagesInternational Forum on Medical Imaging in Asia 2019 2019; : 13 doi: 10.1117/12.2521021
103
Giovanni Morana, Luigi Grazioli, Miles A. Kirchin, Maria Pia Bondioni, Niccolò Faccioli, Alessandro Guarise, Günther Schneider. Solid Hypervascular Liver LesionsInvestigative Radiology 2011; 46(4): 225 doi: 10.1097/RLI.0b013e3181feee3a